Drugs by condition
Drugs approved for huntington's disease chorea
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
0
Still marketed, NDA or BLA
Drug classes
0
Novel drugs
0
New molecular entities and new biologics
In development
6
Investigational drugs in Phase 2 or 3
All approved drugs for huntington's disease chorea, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
No current brand-name label names this in its indications. Try another name for the condition, or a broader term.
Drugs in development for huntington's disease chorea
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- SKY-0515Phase 33 trials
Skyhawk Therapeutics, Inc. · Huntington Disease, Huntingtons Disease, Huntington's Disease (HD)
- PridopidinePhase 32 trials
Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease
- ER2001Phase 21 trial
ExoRNA Bioscience · Huntington Disease
- MBF-015Phase 21 trial
Medibiofarma S.L. · Huntington Disease
- TominersenRO7234292, RG6042Phase 21 trial
Roche (Genentech) · Huntington Disease
- VO659Phase 21 trial
Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
More on huntington's disease chorea: recruiting trials · published research
Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Tardive dyskinesia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.